Regulatory tracker: FDA nod for AbbVie's Mayvret allows it to be provided immediately upon hep C diagnosis
In this tracker, Fierce Pharma is recording the regulatory progress of in-market products, including expansions into key geographies and new indications. Some of these updates may not meet the bar for standalone stories, but we think they are still worth mentioning.
